SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as discussions revolve around the potential impact of recent FDA news related to AI-assisted tools in MASH clinical trials, specifically regarding biopsy analysis and trial efficiency. The community is actively speculating on upcoming catalysts, including 48-week data and a potential FDA meeting, with some expressing optimism about accelerated approval pathways and buyout possibilities, while others urge caution.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

AlphaTime Acquisition Corp ($ATMC) is trending after shareholder approval of its merger with HCYC, a Hong Kong-based insurance brokerage, triggering a massive after-hours surge. The community is discussing the low float, potential for a short squeeze, and comparing it to similar plays like $SMX, with some speculating on targets, while others caution about the risks of chasing low-float stocks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending amid community excitement surrounding upcoming catalysts and potential government support in the rare earths sector. Bullish sentiment is fueled by speculation around the BFS report and potential EU-backed deals, with some traders eyeing a return to previous highs. Discussions also involve the company's financials and the strategic importance of rare earth elements.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending due to positive Phase 2 data for its multiple myeloma treatment, driving significant after-hours volume. The community is focused on the stock's low float and potential for a short squeeze, while some traders caution about chasing the rally. Links to the news and potential catalysts are being shared.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to JP Morgan's recent Overweight rating and a $43 price target, sparking community discussion around the large discrepancy between the target and a previous offering price.  The stock is also experiencing increased momentum and high trading volume, leading to speculation about a potential short squeeze and further price appreciation. Community members are actively debating the merits of the stock and watching for potential entry and exit points.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

ATMV is trending due to discussions around a potential merger, reminiscent of other SPACs that have seen significant volatility. Community chatter highlights the stock's low float and high borrow fees, leading to speculation about potential short squeezes and comparisons to similar runners. The stock has experienced significant price swings and trading volume, prompting both bullish and bearish sentiment.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

CVKD is trending as community members highlight its bullish technicals, steady accumulation, and potential for a breakout. Recent news regarding pipeline expansion and upcoming presentations at healthcare conferences seem to be driving increased attention. Traders are also discussing the stock's low float, which they believe could lead to significant volatility and price movement.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is trending amid speculation of a hostile takeover bid for Warner Bros. Discovery (WBD), potentially outbidding Netflix; the community is actively discussing the likelihood of regulatory approval, potential financial implications, and which company offers the best deal for WBD shareholders. Community members are weighing the impact of a potential merger with WBD against the company's prospects as a standalone entity.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending as traders discuss its potential for a short squeeze, citing its low float and recent breakout. Community members are pointing to the stock's AI data center and energy focus as catalysts, comparing it to other low-float stocks that have recently experienced parabolic runs. Watchers are growing, and some anticipate a significant upward move if certain price levels are breached.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BCTX is trending due to investor anticipation surrounding upcoming data presentations at the San Antonio Breast Cancer Symposium (SABCS) and positive momentum from Phase 3 MBC study. Community discussions revolve around encouraging Phase 2 survival data, strong Phase 3 safety, and biomarker readouts. Some are speculating on the potential for a buyout due to the company's low market cap and insider ownership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMWD
Share Price: $56.98

Contract Selected: Jul 17, 2026 $60 Calls

Buy Zone: $3.57 – $4.41
Target Zone: $6.69 – $8.17
Potential Upside: 77% ROI

Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/

Every trade is a home run. Over 96% win rate on all trades for the past two years, over 1,000,000+ total trades. Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute financial advice. Trading involves risk, and past performance is not indicative of future results.

Fxcapta

fxcapta.com

StockTwits Web

American Woodmark Corp.


Share Price: $56.98

Contract Selected: Jul 17, 2026 $60 Calls

Buy Zone: $3.57 – $4.41
Target Zone: $6.69 – $8.17
Potential Upside: 77% ROI

Time to Expiration: 224 Days | Updates via 